Table 1 Summary of cases subjected to chromogenic in situ hybridisation and microarray-based comparative genomic hybridisation

From: Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

Case

Type

Gradea

ER/PRb

HER2 CISH

HER2 aCGH

TOP2A CISH

TOP2A aCGH

qRT-PCR

A11735P

MIMP

3

−ve/−ve

Amp

Amp

Not Amp

Not Amp

Yes

M13

IDC

3

+ve/−ve

Amp

Amp

Not Ampc

Not Amp

Yes

M324

IDC

3

+ve/+ve

Amp

Amp

Not Amp

Not Amp

Yes

M345

IDC

3

+ve/+ve

Amp

Amp

Not Amp

Not Amp

Yes

M348

IDC

3

−ve/−ve

Amp

Amp

Not Amp

Not Amp

Yes

M37

IDC

3

+ve/−ve

Amp

Amp

Amp

Amp

Yes

M61

P-ILC

3

+ve/−ve

Amp

Amp

Amp

Amp

Yes

M166

IDC

3

+ve/−ve

Amp

Amp

Amp

Amp

Yes

M168

IDC

3

+ve/+ve

Amp

Amp

Amp

Amp

Yes

M180

IDC

3

−ve/−ve

Amp

Amp

Amp

Amp

Yes

M275

IDC

3

+ve/+ve

Amp

Amp

Amp

Amp

Yes

M300

IDC

2

+ve/+ve

Amp

Amp

Amp

Amp

Yes

M309

IDC

3

−ve/−ve

Amp

Amp

Amp

Amp

Yes

M312

Mixed

3

+ve/+ve

Amp

Amp

Amp

Amp

Yes

X644

MIMP

3

−ve/−ve

Amp

Amp

Amp

Amp

Yes

M346

Mixed

2

+ve/+ve

Amp

NA

Not Amp

NA

Yes

M144

IDC

3

−ve/+ve

Amp

NA

Not Amp

NA

Yes

M347

IDC

3

+ve/+ve

Amp

NA

Not Amp

NA

Yes

M327

IDC

3

−ve/+ve

Amp

NA

Not Amp

NA

Yes

M19

IDC

3

+ve/+ve

Amp

NA

Not Amp

NA

Yes

M230

IDC

3

+ve/+ve

Amp

NA

Not Amp

NA

Yes

M259

IDC

3

+ve/+ve

Amp

NA

Not Amp

NA

Yes

M257

IDC

3

−ve/+ve

Amp

NA

Amp

NA

Yes

M316

IDC

3

+ve/+ve

Amp

NA

Amp

NA

Yes

M337

IDC

2

+ve/+ve

Amp

NA

Amp

NA

Yes

M245

IDC

3

+ve/+ve

Amp

NA

Amp

NA

Yes

M270

IDC

2

−ve/−ve

Amp

NA

Amp

NA

Yes

  1. aBloom–Richardson–Scarff histological grade.
  2. bAs defined by an Allred score ≥3.
  3. cThis case showed low-level copy ‘amplification’ using only the TOP2A probe. When ratios TOP2A:CEP17 were devised, the case lacked TOP2A gene amplification.
  4. −ve, negative; +ve, positive.
  5. aCGH, microarray-based comparative genomic hybridisation; Amp, amplified; CISH, chromogenic in situ hybridisation; IDC, invasive ductal carcinoma of no special type; MIMP, mixed invasive micropapillary carcinoma; mixed, mixed invasive ductal and lobular carcinoma; not Amp, not amplified; NA, not assessable due to failed quality control PCR; P-ILC, pleomorphic lobular carcinoma.